EVT.DE vs. IBRX
EVT.DE (Evotec SE) and IBRX (ImmunityBio, Inc.) are both stocks. Both are in the Healthcare sector — EVT.DE in Drug Manufacturers - Specialty & Generic, IBRX in Biotechnology. Over the past 10 years, EVT.DE returned 2.52%/yr vs 1.27%/yr for IBRX. At a 0.14 correlation, their price movements are largely independent.
Performance
EVT.DE vs. IBRX - Performance Comparison
Loading charts...
Different Trading Currencies
EVT.DE is traded in EUR, while IBRX is traded in USD. To make them comparable, the IBRX values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, EVT.DE achieves a -9.17% return, which is significantly lower than IBRX's 327.15% return. Over the past 10 years, EVT.DE has outperformed IBRX with an annualized return of 2.52%, while IBRX has yielded a comparatively lower 1.27% annualized return.
EVT.DE
- 1D
- -0.80%
- 1M
- 6.22%
- 6M
- -21.92%
- YTD
- -9.17%
- 1Y
- -29.79%
- 3Y*
- -38.55%
- 5Y*
- -33.06%
- 10Y*
- 2.52%
IBRX
- 1D
- -7.21%
- 1M
- 17.32%
- 6M
- 259.56%
- YTD
- 327.15%
- 1Y
- 199.46%
- 3Y*
- 45.74%
- 5Y*
- -8.13%
- 10Y*
- 1.27%
EVT.DE vs. IBRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EVT.DE Evotec SE | -9.17% | -33.54% | -61.47% | 39.45% | -64.09% | 40.36% | 31.37% | 32.78% | 28.59% | 81.45% |
IBRX ImmunityBio, Inc. | 327.15% | -31.83% | -45.64% | -3.95% | -11.44% | -50.98% | 222.72% | 234.11% | -72.95% | -31.15% |
Correlation
The correlation between EVT.DE and IBRX is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jul 28, 2015 | 0.14 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EVT.DE vs. IBRX — Risk / Return Rank
EVT.DE
IBRX
EVT.DE vs. IBRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Evotec SE (EVT.DE) and ImmunityBio, Inc. (IBRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EVT.DE | IBRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.44 | ||
| Sortino ratioReturn per unit of downside risk | -3.47 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 1.35 | -0.43 |
| Calmar ratioReturn relative to maximum drawdown | -0.70 | 4.75 | -5.45 |
| Martin ratioReturn relative to average drawdown | -1.20 | 7.84 | -9.05 |
Loading charts...
Drawdowns
EVT.DE vs. IBRX - Drawdown Comparison
The maximum EVT.DE drawdown since its inception was -90.92%, smaller than the maximum IBRX drawdown of -97.36%. Use the drawdown chart below to compare losses from any high point for EVT.DE and IBRX.
Loading charts...
Drawdown Indicators
| EVT.DE | IBRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.92% | -97.36% | +6.44% |
Max Drawdown (1Y)Largest decline over 1 year | -44.77% | -40.98% | -3.79% |
Max Drawdown (3Y)Largest decline over 3 years | -83.00% | -80.35% | -2.65% |
Max Drawdown (5Y)Largest decline over 5 years | -90.92% | -88.15% | -2.77% |
Max Drawdown (10Y)Largest decline over 10 years | -90.92% | -96.59% | +5.67% |
Current DrawdownCurrent decline from peak | -89.08% | -79.28% | -9.80% |
Average DrawdownAverage peak-to-trough decline | -39.34% | -84.06% | +44.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.94% | 24.78% | +1.16% |
Volatility
EVT.DE vs. IBRX - Volatility Comparison
The current volatility for Evotec SE (EVT.DE) is 9.07%, while ImmunityBio, Inc. (IBRX) has a volatility of 20.54%. This indicates that EVT.DE experiences smaller price fluctuations and is considered to be less risky than IBRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EVT.DE | IBRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.07% | 20.54% | -11.47% |
Volatility (6M)Calculated over the trailing 6-month period | 38.12% | 89.04% | -50.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 53.07% | 105.31% | -52.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 57.96% | 112.85% | -54.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.26% | 111.04% | -59.78% |
Dividends
EVT.DE vs. IBRX - Dividend Comparison
Neither EVT.DE nor IBRX has paid dividends to shareholders.
Financials
EVT.DE vs. IBRX - Financials Comparison
This section allows you to compare key financial metrics between Evotec SE and ImmunityBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
EVT.DE and IBRX have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for EVT.DE and IBRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer